Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Marta Almeria, Ignacio Alvarez, Jessica Molina-Seguin, Sarah Besora, Mariateresa Buongiorno, Silvia Romero, Laura Casas, Cristina Cano, Judith Castejon, Sonia Arribas & Jerzy Krupinski. (2023) Citicoline May Prevent Cognitive Decline in Patients with Cerebrovascular Disease. Clinical Interventions in Aging 18, pages 1093-1102.
Read now
Read now
Daniele Lo Coco, Gianluca Lopez & Salvatore Corrao. (2016) Cognitive impairment and stroke in elderly patients. Vascular Health and Risk Management 12, pages 105-116.
Read now
Read now
Pietro Gareri, Alberto Castagna, Antonino Maria Cotroneo, Salvatore Putignano, Giovambattista De Sarro & Amalia Cecilia Bruni. (2015) The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. Clinical Interventions in Aging 10, pages 1421-1429.
Read now
Read now
Steven E. Bruce, Kimberly B. Werner, Brittany F. Preston & Laurie M. Baker. (2014) Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline–caffeine beverage. International Journal of Food Sciences and Nutrition 65:8, pages 1003-1007.
Read now
Read now
Articles from other publishers (16)
L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova & M. S. Shchepankevich. (2022) Mild cognitive impairment treatment issues. Neurology, Neuropsychiatry, Psychosomatics 14:6, pages 110-114.
Crossref
Crossref
Stephen H. Sinclair, Elan Miller, Kiran S. Talekar & Stanley S. Schwartz. (2022) Diabetes mellitus associated neurovascular lesions in the retina and brain: A review. Frontiers in Ophthalmology 2.
Crossref
Crossref
Maciej Świątkiewicz & Paweł Grieb. (2022) Citicoline for Supporting Memory in Aging Humans. Aging and disease, pages 0.
Crossref
Crossref
Paweł Grieb, Maciej Świątkiewicz, Agnieszka Kamińska, Anselm Jünemann, Robert Rejdak & Konrad Rejdak. (2021) Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis. Pharmaceuticals 14:4, pages 326.
Crossref
Crossref
A.N. Bogolepova, E.E. Vasenina, N.A. Gomzyakova, E.I. Gusev, N.G. Dudchenko, A.Yu. Emelin, N.M. Zalutskaya, R.I. Isaev, Yu.V. Kotovskaya, O.S. Levin, I.V. Litvinenko, V.Yu. Lobzin, M.Yu. Martynov, E.A. Mkhitaryan, G.N. Nikolay, E.I. Palchikova, O.N. Tkacheva, M.A. Cherdak, A.S. Chimagomedova & N.N. Yakhno. (2021) Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:10, pages 6.
Crossref
Crossref
I.A. Voznyuk, N.N. Zavadenko, P.R. Kamchatnov, O.S. Levin, V.A. Parfenov, E.Yu. Solovieva & D.R. Hasanova. (2021) Results of the round table: modern approaches to drug therapy of cognitive impairment in cerebrovascular pathology. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:8, pages 147.
Crossref
Crossref
Т. М. Ostroumova, О. D. Ostroumova & О. V. Golovina. (2020) Early signs of hypertension-mediated brain damage: case report and possibilities of citicoline. Medical alphabet 1:19, pages 24-28.
Crossref
Crossref
Patryk Jasielski, Faustyna Piędel, Mikołaj Piwek, Agata Rocka, Véronique Petit & Konrad Rejdak. (2020) Application of Citicoline in Neurological Disorders: A Systematic Review. Nutrients 12:10, pages 3113.
Crossref
Crossref
Pietro Gareri, Luca Gallelli, Antonino Maria Cotroneo, Valeria Graziella Laura Manfredi & Giovambattista De Sarro. (2020) The Art of Safe and Judicious Deprescribing in an Elderly Patient: A Case Report. Geriatrics 5:3, pages 57.
Crossref
Crossref
A. N. Bogolepova, S. G. Burd, A. V. Lebedeva & E. A. Kovalenko. (2020) Experience with citicoline in patients with post-stroke cognitive impairment. Neurology, Neuropsychiatry, Psychosomatics 12:4, pages 43-48.
Crossref
Crossref
A. Yu. Emelin & V. Yu. Lobzin. (2020) Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises. Neurology, Neuropsychiatry, Psychosomatics 12:4, pages 131-136.
Crossref
Crossref
Sonali Nashine & M. Cristina Kenney. (2020) Role of Citicoline in an in vitro AMD model. Aging 12:10, pages 9031-9040.
Crossref
Crossref
V. A. Golovacheva. (2020) The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment. Neurology, Neuropsychiatry, Psychosomatics 12:2, pages 119-124.
Crossref
Crossref
G. Z. Sufianova, A. G. Shapkin, A. A. Sufianov, M. S. Khlеstkina, R. A. Sufianov & A. M. Mashkin. (2019) Comparative evaluation of pre- and postoperative administration of citicoline: clinical outcomes and the volume of ischemic brain damage after meningioma removal. Sechenov Medical Journal 10:4, pages 12-20.
Crossref
Crossref
P Gareri & A Castagna. (2017) Citicoline in Vascular Cognitive Impairment: Some Latest Evidences. Annals of Alzheimer's and Dementia Care 1:1, pages 018-019.
Crossref
Crossref
Alberto Castagna, Antonino Maria Cotroneo, Giovanni Ruotolo & Pietro Gareri. (2016) The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study. Clinical Drug Investigation 36:12, pages 1059-1065.
Crossref
Crossref